These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38051383)

  • 1. Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa.
    Reddy K; Palanee-Phillips T; Heffron R
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):333-344. PubMed ID: 38051383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of HIV Pre-exposure Prophylaxis use Among Adolescent Girls and Young Women Accessing Routine Sexual and Reproductive Health services in South Africa.
    Martin CE; Cox LA; Nongena P; Butler V; Ncube S; Sawry S; Mullick S
    J Adolesc Health; 2023 Dec; 73(6S):S81-S91. PubMed ID: 37953014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L; Mudzingwa EK; Fynn L; Atujuna M; Mugore M; Gandhi M; Celum C; Hosek S; Bekker LG; Daniels J; Medina-Marino A
    J Int AIDS Soc; 2023 Sep; 26(9):e26175. PubMed ID: 37758649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
    Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
    AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.
    Bonner CP; Browne FA; Carney T; Shangase N; Ndirangu JW; Myers B; Wechsberg WM
    S Afr Med J; 2022 Apr; 112(5):341-346. PubMed ID: 35587247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
    BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D; Gill K; Fynn L; Duyver M; O'Rourke S; van der Straten A; Morton JF; Celum CL; Bekker LG
    PLoS One; 2021; 16(3):e0248307. PubMed ID: 33667264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL; Bukusi EA; Bekker LG; Delany-Moretlwe S; Kidoguchi L; Omollo V; Rousseau E; Travill D; Morton JF; Mogaka F; O'Malley G; Barnabee G; van der Straten A; Donnell D; Parikh UM; Kudrick L; Anderson PL; Haberer JE; Wu L; Heffron R; Johnson R; Morrison S; Baeten JM;
    J Int AIDS Soc; 2022 Jul; 25(7):e25962. PubMed ID: 35822945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa.
    Bergh K; Toska E; Duby Z; Govindasamy D; Mathews C; Reddy T; Jonas K
    AIDS Behav; 2024 Apr; 28(4):1137-1151. PubMed ID: 37462890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Risk Factors of PrEP Use Stigma Among Adolescent Girls and Young Women in Johannesburg, South Africa and Mwanza, Tanzania Participating in the EMPOWER Trial.
    Munthali RJ; Stangl AL; Baron D; Barré I; Harvey S; Ramskin L; Colombini M; Naicker N; Kapiga S; Delany-Moretlwe S;
    AIDS Behav; 2022 Dec; 26(12):3950-3962. PubMed ID: 35776254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of HIV Pre-exposure Prophylaxis Among Men Accessing Routine Sexual and Reproductive Health Services in South Africa.
    Cox LA; Martin CE; Nongena P; Mvelase S; Kutywayo A; Mullick S
    J Adolesc Health; 2023 Dec; 73(6S):S92-S100. PubMed ID: 37953015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing Differentiated and Integrated HIV Prevention Services for Adolescent Girls and Young Women: Experiences From Oral PrEP Rollout in Primary Care Services in South Africa.
    Butler V; Kutywayo A; Martin CE; Pleaner M; Mojapele MV; Ncube S; Fipaza Z; Mundeta B; Mullick S
    J Adolesc Health; 2023 Dec; 73(6S):S58-S66. PubMed ID: 37953010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda.
    Lunkuse JF; Kamacooko O; Muturi-Kioi V; Chinyenze K; Kuteesa MO; Price MA; Mayanja Y
    BMC Infect Dis; 2022 May; 22(1):467. PubMed ID: 35578163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
    Hartmann M; Nyblade L; Otticha S; Marton T; Agot K; Roberts ST
    J Int AIDS Soc; 2024 Feb; 27(2):e26213. PubMed ID: 38379129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.